Sentry Investment Management LLC Sells 1,443 Shares of The Procter & Gamble Company (NYSE:PG)

Sentry Investment Management LLC reduced its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 7.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,726 shares of the company’s stock after selling 1,443 shares during the quarter. Procter & Gamble accounts for approximately 1.0% of Sentry Investment Management LLC’s investment portfolio, making the stock its 14th biggest holding. Sentry Investment Management LLC’s holdings in Procter & Gamble were worth $2,487,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. Moneta Group Investment Advisors LLC raised its position in shares of Procter & Gamble by 96,526.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock valued at $5,840,449,000 after purchasing an additional 38,495,676 shares during the period. Norges Bank bought a new position in shares of Procter & Gamble in the fourth quarter valued at about $3,752,321,000. Morgan Stanley raised its position in shares of Procter & Gamble by 12.6% in the fourth quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock valued at $6,717,246,000 after purchasing an additional 4,959,527 shares during the period. Alliancebernstein L.P. raised its position in shares of Procter & Gamble by 43.9% in the fourth quarter. Alliancebernstein L.P. now owns 9,462,510 shares of the company’s stock valued at $1,434,138,000 after purchasing an additional 2,888,007 shares during the period. Finally, CI Private Wealth LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at about $292,647,000. 64.65% of the stock is owned by institutional investors.

Procter & Gamble Trading Up 0.7 %

PG opened at $150.05 on Friday. The company’s 50 day moving average is $149.25 and its 200-day moving average is $147.25. The Procter & Gamble Company has a 1-year low of $122.18 and a 1-year high of $158.11. The company has a current ratio of 0.59, a quick ratio of 0.39 and a debt-to-equity ratio of 0.51. The company has a market cap of $353.66 billion, a P/E ratio of 26.14, a PEG ratio of 3.83 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 21st. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The company had revenue of $20.07 billion for the quarter, compared to the consensus estimate of $19.32 billion. During the same period last year, the company posted $1.33 EPS. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. Equities research analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Friday, July 21st will be paid a $0.9407 dividend. The ex-dividend date of this dividend is Thursday, July 20th. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.51%. Procter & Gamble’s payout ratio is currently 65.51%.

Insider Activity

In other news, insider Susan Street Whaley sold 4,852 shares of the firm’s stock in a transaction that occurred on Wednesday, April 26th. The shares were sold at an average price of $155.47, for a total value of $754,340.44. Following the sale, the insider now directly owns 7,977 shares in the company, valued at approximately $1,240,184.19. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $156.03, for a total transaction of $4,836,930.00. Following the sale, the chief operating officer now directly owns 10,014 shares in the company, valued at approximately $1,562,484.42. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Susan Street Whaley sold 4,852 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total transaction of $754,340.44. Following the sale, the insider now owns 7,977 shares in the company, valued at $1,240,184.19. The disclosure for this sale can be found here. In the last three months, insiders have sold 95,093 shares of company stock worth $14,821,930. Corporate insiders own 0.26% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Barclays increased their price objective on shares of Procter & Gamble from $160.00 to $167.00 in a research report on Wednesday, April 26th. Raymond James upped their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Sunday, April 23rd. Truist Financial downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price target for the company from $165.00 to $155.00 in a research note on Thursday, May 18th. Morgan Stanley upped their price target on shares of Procter & Gamble from $160.00 to $174.00 and gave the company an “overweight” rating in a research note on Monday, April 24th. Finally, StockNews.com initiated coverage on shares of Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Five research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $161.50.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.